{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:31:37Z","timestamp":1787869897646,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.soc.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T21:23:24Z","timestamp":1472851404000},"page":"789-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Malignant Peripheral Nerve Sheath Tumor"],"prefix":"10.1016","volume":"25","author":[{"given":"Aaron W.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Shurell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Dry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz C.","family":"Eilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.soc.2016.05.009_bib1","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/cncr.20570","article-title":"Validation of the postoperative nomogram for 12-year sarcoma-specific mortality","volume":"101","author":"Eilber","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2016.05.009_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jso.20971","article-title":"Malignant Peripheral Nerve Sheath Tumor: molecular pathogenesis and current management considerations","volume":"97","author":"Grobmyer","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2016.05.009_bib3","first-page":"168","article-title":"Malignant peripheral nerve sheath tumors: an update","volume":"14","author":"Fuchs","year":"2005","journal-title":"J\u00a0Surg Orthop Adv"},{"issue":"8\u20139","key":"10.1016\/j.soc.2016.05.009_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000226591","article-title":"Treatment of a malignant peripheral nerve sheath tumor","volume":"32","author":"Lin","year":"2009","journal-title":"Onkologie"},{"issue":"10","key":"10.1016\/j.soc.2016.05.009_bib5","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.soc.2016.05.009_bib6","doi-asserted-by":"crossref","first-page":"e47595","DOI":"10.1371\/journal.pone.0047595","article-title":"Impaired Pten expression in human malignant peripheral nerve sheath tumours","volume":"7","author":"Bradtmoller","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.soc.2016.05.009_bib7","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.soc.2016.05.009_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","article-title":"Association between benign and malignant peripheral nerve sheath tumors in NF1","volume":"65","author":"Tucker","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.soc.2016.05.009_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.soc.2016.05.009_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.1986.tb48062.x","article-title":"Neurofibromatosis and cancer","volume":"486","author":"Bader","year":"1986","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.soc.2016.05.009_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function: narrowing the GAP","volume":"104","author":"Cichowski","year":"2001","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/1097-0142(19830315)51:6<1028::AID-CNCR2820510610>3.0.CO;2-3","article-title":"Postirradiation neurofibrosarcoma","volume":"51","author":"Ducatman","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2016.05.009_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1186\/1471-2407-14-827","article-title":"Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients","volume":"14","author":"Shurell","year":"2014","journal-title":"BMC Cancer"},{"issue":"33","key":"10.1016\/j.soc.2016.05.009_bib14","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1200\/JCO.2005.01.4886","article-title":"Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group","volume":"23","author":"Carli","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2016.05.009_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2016.05.009_bib16","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1017\/S1462399409001227","article-title":"Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways","volume":"11","author":"Katz","year":"2009","journal-title":"Expert Rev Mol Med"},{"issue":"2","key":"10.1016\/j.soc.2016.05.009_bib17","first-page":"777","article-title":"Diagnosis, treatment and survival of 65 patients with malignant peripheral nerve sheath tumors","volume":"34","author":"Goertz","year":"2014","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.soc.2016.05.009_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0360-3016(98)00223-5","article-title":"Malignant peripheral nerve sheath tumor: analysis of treatment outcome","volume":"42","author":"Wong","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R","article-title":"Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases","volume":"66","author":"Hruban","year":"1990","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.soc.2016.05.009_bib20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2191::AID-CNCR14>3.0.CO;2-P","article-title":"Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors","volume":"82","author":"Kourea","year":"1998","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.soc.2016.05.009_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/annonc\/mdq338","article-title":"First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study","volume":"22","author":"Kroep","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2016.05.009_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1750-1172-8-127","article-title":"Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review","volume":"8","author":"Zehou","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"5447","key":"10.1016\/j.soc.2016.05.009_bib23","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumor development in neurofibromatosis type 1","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.soc.2016.05.009_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2005.11.042","article-title":"PTEN function in normal and neoplastic growth","volume":"241","author":"Chow","year":"2006","journal-title":"Cancer Lett"},{"issue":"46","key":"10.1016\/j.soc.2016.05.009_bib25","doi-asserted-by":"crossref","first-page":"19479","DOI":"10.1073\/pnas.0910398106","article-title":"PTEN dosage is essential for neurofibroma development and malignant transformation","volume":"106","author":"Gregorian","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"13","key":"10.1016\/j.soc.2016.05.009_bib26","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/0008-5472.CAN-11-4092","article-title":"PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors","volume":"72","author":"Keng","year":"2012","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.soc.2016.05.009_bib27","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1158\/1078-0432.CCR-11-1707","article-title":"Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment","volume":"17","author":"Yang","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.soc.2016.05.009_bib28","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1172\/JCI7610","article-title":"Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models","volume":"105","author":"DeClue","year":"2000","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.soc.2016.05.009_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1634\/theoncologist.2013-0328","article-title":"Malignant peripheral nerve sheath tumors","volume":"19","author":"Farid","year":"2014","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181a77e9a","article-title":"Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome","volume":"249","author":"Zou","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.soc.2016.05.009_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cncr.24755","article-title":"Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign","volume":"116","author":"Benz","year":"2010","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.soc.2016.05.009_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00234-003-0964-6","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma","volume":"45","author":"Mautner","year":"2003","journal-title":"Neuroradiology"},{"key":"10.1016\/j.soc.2016.05.009_bib33","series-title":"Tumors of the central nervous system","first-page":"161","article-title":"Peripheral nerve sheath tumors: diagnosis using quantitative FDG-PET","author":"Shurell","year":"2012"},{"issue":"4","key":"10.1016\/j.soc.2016.05.009_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/CCO.0b013e32832c95e2","article-title":"Utilization of positron emission tomography in the management of patients with sarcoma","volume":"21","author":"Benz","year":"2009","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"10.1016\/j.soc.2016.05.009_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1055\/s-0035-1553505","article-title":"Multimodal imaging in neurofibromatosis type 1-associated nerve sheath tumors","volume":"187","author":"Salamon","year":"2015","journal-title":"Rofo"},{"issue":"7","key":"10.1016\/j.soc.2016.05.009_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00432-008-0523-y","article-title":"Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI","volume":"135","author":"Matsumine","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib37","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2214\/AJR.09.2724","article-title":"MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas","volume":"194","author":"Wasa","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.soc.2016.05.009_bib38","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/RLU.0b013e318266ce84","article-title":"Comparative effectiveness of 18F-FDG PET\/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1","volume":"38","author":"Derlin","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1016\/j.soc.2016.05.009_bib39","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3174\/ajnr.A3910","article-title":"Conventional and functional MR imaging of peripheral nerve sheath tumors: initial experience","volume":"35","author":"Demehri","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.soc.2016.05.009_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp.68.3.353","article-title":"Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1","volume":"68","author":"Ferner","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.soc.2016.05.009_bib41","series-title":"Enzinger and Weiss's soft tissue tumors","first-page":"xiv","author":"Goldblum","year":"2014"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF02307086","article-title":"Malignant peripheral nerve sheath tumors: the St. Jude Children's Research Hospital experience","volume":"2","author":"deCou","year":"1995","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2016.05.009_bib43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2559.1988.tb01975.x","article-title":"Malignant nerve sheath tumour with epithelial elements","volume":"12","author":"Cross","year":"1988","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.soc.2016.05.009_bib44","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/00000478-199112000-00004","article-title":"Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma)","volume":"15","author":"Laskin","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.soc.2016.05.009_bib45","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors: diagnostic features and molecular genetics","volume":"35","author":"Hollmann","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.soc.2016.05.009_bib46","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/1097-0142(19851101)56:9<2269::AID-CNCR2820560922>3.0.CO;2-#","article-title":"Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwannoma)","volume":"56","author":"Matsunou","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.soc.2016.05.009_bib47","first-page":"299","article-title":"Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors","volume":"49","author":"Weiss","year":"1983","journal-title":"Lab Invest"},{"issue":"9","key":"10.1016\/j.soc.2016.05.009_bib48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/PAS.0b013e3181658c14","article-title":"Sox10: a pan-schwannian and melanocytic marker","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1309\/AJCP45SSNAOPXYXU","article-title":"Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics","volume":"135","author":"Foo","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.soc.2016.05.009_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#","article-title":"Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis","volume":"89","author":"Woodruff","year":"1999","journal-title":"Am J Med Genet"},{"issue":"Pt 2","key":"10.1016\/j.soc.2016.05.009_bib51","first-page":"1","article-title":"Peripheral nerve sheath neoplasms. Clinicopathologic and immunochemical observations","volume":"30","author":"Swanson","year":"1995","journal-title":"Pathol Annu"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib52","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-006-0171-8","article-title":"Low grade malignant peripheral nerve sheath tumor with smooth muscle differentiation","volume":"113","author":"Rodriguez","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1016\/j.soc.2016.05.009_bib53","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/00000478-199909000-00024","article-title":"Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors","volume":"23","author":"Liapis","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.soc.2016.05.009_bib54","series-title":"WHO classification of tumours of soft tissue and bone","author":"Fletcher","year":"2013"},{"key":"10.1016\/j.soc.2016.05.009_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-7819-4-55","article-title":"Malignant peripheral nerve sheath tumors (MPNST)\u2013clinicopathological study and treatment outcome of twenty-four cases","volume":"4","author":"Kar","year":"2006","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2016.05.009_bib56","first-page":"413","article-title":"High grade malignant peripheral nerve sheath tumors: outcome of 62 patients with localized disease and review of the literature","volume":"22","author":"Longhi","year":"2010","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.soc.2016.05.009_bib57","doi-asserted-by":"crossref","first-page":"756395","DOI":"10.1155\/2009\/756395","article-title":"Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis type 1-associated tumours","volume":"2009","author":"Porter","year":"2009","journal-title":"Sarcoma"},{"issue":"1","key":"10.1016\/j.soc.2016.05.009_bib58","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2005.04.160","article-title":"Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution","volume":"23","author":"Gronchi","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2016.05.009_bib59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/jso.23736","article-title":"The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma","volume":"110","author":"Bernthal","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.soc.2016.05.009_bib60","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fonc.2014.00324","article-title":"Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"4","author":"Kahn","year":"2014","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.soc.2016.05.009_bib61","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience","volume":"19","author":"Stucky","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2016.05.009_bib62","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2016.05.009_bib63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-006-9053-5","article-title":"Clinical relevance of pathological grades of malignant peripheral nerve sheath tumor: a multi-institution TMTS study of 56 cases in Northern Japan","volume":"14","author":"Okada","year":"2007","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320716300229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320716300229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:00:32Z","timestamp":1760961632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320716300229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1055320716300229"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2016.05.009","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant Peripheral Nerve Sheath Tumor","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}